138 related articles for article (PubMed ID: 2460159)
1. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
Gonias SL; Figler NL; Braud LL
Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
[TBL] [Abstract][Full Text] [Related]
2. The temperature-dependent reaction between alpha 2-macroglobulin and streptokinase-plasmin(ogen) complex.
Rajagopalan S; Gonias SL; Pizzo SV
J Biol Chem; 1987 Mar; 262(8):3660-4. PubMed ID: 2434504
[TBL] [Abstract][Full Text] [Related]
3. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.
Gonias SL; Figler NL
Biochem J; 1988 Oct; 255(2):725-30. PubMed ID: 2462416
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
Anonick PK; Wolf B; Gonias SL
Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
[TBL] [Abstract][Full Text] [Related]
5. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
Reddy KN; Cercek B; Lew AS; Ganz W
Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
[TBL] [Abstract][Full Text] [Related]
6. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
Anonick PK; Gonias SL
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
Hall SW; Humphries JE; Gonias SL
J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.
Anonick PK; Vetter WH; Gonias SL
Biochem J; 1989 Dec; 264(3):745-52. PubMed ID: 2482733
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
Anonick PK; Yoo JK; Webb DJ; Gonias SL
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
11. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
Gonias SL; Einarsson M; Pizzo SV
J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
[TBL] [Abstract][Full Text] [Related]
12. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
[TBL] [Abstract][Full Text] [Related]
13. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin.
Heeb MJ; Gruber A; Griffin JH
J Biol Chem; 1991 Sep; 266(26):17606-12. PubMed ID: 1716632
[TBL] [Abstract][Full Text] [Related]
14. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
Zhabin SG; Zorin NA; Musatov MI
Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
16. The regulation of human factor XIIa by plasma proteinase inhibitors.
Pixley RA; Schapira M; Colman RW
J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
[TBL] [Abstract][Full Text] [Related]
17. Blood inhibitory capacity toward exogenous plasmin.
Banbula A; Zimmerman TP; Novokhatny VV
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):241-6. PubMed ID: 17413760
[TBL] [Abstract][Full Text] [Related]
18. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
Silence K; Collen D; Lijnen HR
Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of alpha 2-antiplasmin by limited reaction with cis-dichlorodiammineplatinum (II).
Geary WA; Gonias SL
Biochim Biophys Acta; 1989 Jan; 994(1):1-6. PubMed ID: 2521201
[TBL] [Abstract][Full Text] [Related]
20. Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.
Reed GL; Matsueda GR; Haber E
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1114-8. PubMed ID: 1689060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
